Soligenix Inc. (NASDAQ: SNGX) Announces Positive Phase 2 Data for Rare Inflammatory Disease
Behçet’s disease is characterized by unpredictable flare-ups and periods of remission, making long-term management particularly challenging. Current treatment strategies for…